Early research (Phase 1)Study completedNCT04468607What this trial is testingBLYG8824A in Participants With Locally Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Genentech, Inc. 46
Early research (Phase 1)Ended earlyNCT02908451What this trial is testingAbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary CancerWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+1 more AbGenomics B.V Taiwan Branch 39
Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Ended earlyNCT04000529What this trial is testingPhase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesWho this might be right forNon-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT00056446What this trial is testingStudy of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerWho this might be right forColorectal NeoplasmsColonic NeoplasmsRectal Neoplasms Novartis Pharmaceuticals 855
Large-scale testing (Phase 3)Study completedNCT00766155What this trial is testingChemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal CancerWho this might be right forColorectal Cancer European Organisation for Research and Treatment of Cancer - EORTC 1,094
Testing effectiveness (Phase 2)Ended earlyNCT01605318What this trial is testingStudy of Labetuzumab Govitecan in Participants With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal CancerColon CancerRectal Cancer Gilead Sciences 92
Not applicableEnded earlyNCT02439008What this trial is testingEarly Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseWho this might be right forCarcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more Centre Oscar Lambret 28
Large-scale testing (Phase 3)Study completedNCT01931150What this trial is testingStudy of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RTWho this might be right forCetuximab-induced Papulopustular (Acneiform) Rash Who HaveMetastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma Memorial Sloan Kettering Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00004150What this trial is testingHigh-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon CancerWho this might be right forColorectal Cancer Robert Roessle Klinik
Early research (Phase 1)Ended earlyNCT02559024What this trial is testingAnti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Providence Health & Services 4
Testing effectiveness (Phase 2)Ended earlyNCT00908024What this trial is testingCombination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerNeoplasm Metastasis Bristol-Myers Squibb 54
Not applicableStudy completedNCT00899210What this trial is testingMatrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694936What this trial is testingCombining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Australasian Gastro-Intestinal Trials Group 38
Testing effectiveness (Phase 2)Study completedNCT00467844What this trial is testingStudy of GTx-024 on Muscle Wasting (Cachexia) Cancer.Who this might be right forCachexia GTx 159
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Not applicableNot Yet RecruitingNCT07564284What this trial is testingLiver-First, Bowel-First, or Simultaneous Resection for Synchronous Colorectal Liver Metastases: Outcomes, Quality of Life, and Cost-EffectivenessWho this might be right forLiver Metastases From Colorectal Cancer Karolinska Institutet 200
Testing effectiveness (Phase 2)UnknownNCT05684211What this trial is testingAmetumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal CancerWho this might be right forColorectal Cancer Shanghai Celfuture Biotech Co., Ltd. 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608044What this trial is testingBotensilimab and Balstilimab for the Treatment of Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Agenus Inc. 234
Testing effectiveness (Phase 2)Looking for participantsNCT07255664What this trial is testingA FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PCWho this might be right forMetastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced CuraCell TX AB 12